Immunohistochemical verification of ductal differentiation in prostate cancer
Abstract
Tarján M, Lenngren A, Hellberg D, Tot T. Immunohistochemical verification of ductal differentiation in prostate cancer. APMIS 2012; 120: 510–8. Recent studies have shown that patients with prostate carcinomas exhibiting ductal differentiation have an unfavourable prognosis compared with those with purely acinar adenocarcinomas. We studied the expression of nine immunohistochemical markers to evaluate their value in delineating carcinomas with and without ductal differentiation. Thirteen tumours showing cellular characteristics and growth patterns typical of ductal differentiation were identified among 110 analysed prostatectomy specimens. The levels of cytoplasmic expression of chromogranine A (69% vs 19%, p = 0.0003) and nuclear expression of p53 (76% vs 12%, p < 0.0001) as well as nuclear expression of Ki-67 (69% vs 26%, p = 0.0047) in the tumour cells, were found to be statistically significantly different in the two tumour categories. Assessment of chromogranine A, p53 and Ki-67 in prostate carcinoma may serve as useful adjunctive diagnostic tools for delineating more aggressive prostate cancer cases exhibiting ductal differentiation.Keywords
This publication has 33 references indexed in Scilit:
- Pathologic Stage of Prostatic Ductal Adenocarcinoma at Radical ProstatectomyAmerican Journal of Surgical Pathology, 2011
- Ductal Adenocarcinoma of the Prostate: Increased Mortality Risk and Decreased Serum Prostate Specific AntigenJournal of Urology, 2010
- Prostatic Ductal Adenocarcinoma: A Mini ReviewMedical Principles and Practice, 2009
- Clinical significance of p53 alterations in surgically treated prostate cancersLaboratory Investigation, 2008
- An immunohistochemical study of chromogranin A and human epidermal growth factor‐2 expression using initial prostate biopsy specimens from patients with bone metastatic prostate cancerBJU International, 2006
- Prostatic ductal adenocarcinoma showing Bcl‐2 expressionInternational Journal of Urology, 2004
- Prostate carcinoma with testicular or penile metastasesCancer, 2002
- The Morphologic Spectrum of Metastatic Prostatic Adenocarcinoma to the LungAmerican Journal of Clinical Pathology, 2002
- Immunophenotypic Characterization of 225 Prostate Adenocarcinomas With Intermediate or High Gleason ScoresAmerican Journal of Clinical Pathology, 2002
- Ductal (endometrioid) adenocarcinoma of the prostate: a clinicopathological study of 16 casesHistopathology, 1996